Propanc Biopharma, Inc. Common Stock Share Price
NASDAQ: PPCB
Live Propanc Biopharma, Inc. Common Stock Share Price Chart
O H L
Propanc Biopharma, Inc. Common Stock Performance Overview
Days Range
▼
$0.63Low
$0.63High
Markets Today
| Previous Close | $0.63 |
|---|---|
| Open | $0.63 |
| Volume | 35,464 |
| Day's Range | $0.63 - $0.63 |
| 52W Range | NA |
| Market Cap | $1.45 M |
Historical Performance
| 1M Returns | -45.69 |
|---|---|
| 3M Returns | -57.14 |
| 6M Returns | -78.44 |
| 1Y Returns | -98.85 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Propanc Biopharma, Inc. Common Stock Fundamentals
| Market Cap | $1.45 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
| Market Cap | $1.45 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | N/A |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | N/A |
| Profit Margin | N/A |
Propanc Biopharma, Inc. Common Stock Profit & Loss
Quarterly
| Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 |
| Operating Income | -$4.67 M | -$3.65 M | -$6.40 M |
| EBITDA | -$4.67 M | -$3.65 M | -$6.40 M |
| Interest Expense | -$305.65 K | -$58.95 K | -$38.27 K |
| Depreciation | $125 | $229 | $316 |
| Income Before Tax | -$4.84 M | -$3.09 M | -$6.36 M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income + | -$4.84 M | -$3.09 M | -$6.36 M |
| Net Profit Margin | - | - | - |
Propanc Biopharma, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|
| Share Capital | $13.33 K | $13.46 K | $54.87 K |
| Reserve & Surplus | -$129.12 M | -$133.15 M | -$139.61 M |
| Non-Current Liabilities | $42.08 K | $35.25 K | $30.27 K |
| Current Liabilities | $3.57 M | $3.62 M | $3.48 M |
| Total Liabilities | $3.61 M | $3.66 M | $3.51 M |
| Fixed Assets | $2.36 K | $4.40 K | $4.22 K |
| Current Assets | $8.76 M | $7.71 M | $8.22 M |
| Total Assets | $17.98 M | $15.11 M | $14.33 M |
Propanc Biopharma, Inc. Common Stock Cash Flow
Quarterly
| Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|
| Net Income | -$4.84 M | -$3.09 M | -$6.36 M |
| Operating Cash Flow | -$1.94 M | -$999.14 K | -$1.14 M |
| Investing Cash Flow | -$2.49 K | -$2.27 K | -$154 |
| Financing Cash Flow | $2.53 M | $965.10 K | $981.61 K |
| Change in Cash | $590.65 K | -$41.50 K | -$117.53 K |
Propanc Biopharma, Inc. Common Stock Return Calculator
The Propanc Biopharma, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Propanc Biopharma, Inc. Common Stock
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Popular Stocks
FAQs
What is the share price of Propanc Biopharma, Inc. Common Stock today?
Propanc Biopharma, Inc. Common Stock (PPCB) share price as of September 18, 2026 is $0.64. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Propanc Biopharma, Inc. Common Stock?
Yes, Indian Investors can invest in the Propanc Biopharma, Inc. Common Stock (PPCB) Share by opening an international trading account with Angel One.
How can I purchase Propanc Biopharma, Inc. Common Stock shares in India?
Purchasing Propanc Biopharma, Inc. Common Stock (PPCB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Propanc Biopharma, Inc. Common Stock (PPCB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Propanc Biopharma, Inc. Common Stock?
Yes, you can purchase fractional shares of Propanc Biopharma, Inc. Common Stock (PPCB) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Propanc Biopharma, Inc. Common Stock?
The market capitalization of Propanc Biopharma, Inc. Common Stock on September 18, 2026, is $1.45 M.
In which sector Propanc Biopharma, Inc. Common Stock belongs?
Propanc Biopharma, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Propanc Biopharma, Inc. Common Stock stocks?
In order to invest in Propanc Biopharma, Inc. Common Stock (PPCB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
